TY - JOUR
T1 - Comparison of results after heart transplantation
T2 - Mechanically supported versus nonsupported patients
AU - Pifarre, R.
AU - Sullivan, H.
AU - Montoya, A.
AU - Bakhos, M.
AU - Grieco, J.
AU - Foy, B. K.
AU - Blakeman, B.
AU - Costanzo-Nordin, M. R.
AU - Altergott, R.
AU - Lonchyna, V.
AU - Calandra, D.
AU - Hinkamp, T.
AU - Grady, K. L.
AU - Bartlett, L.
PY - 1992/1/1
Y1 - 1992/1/1
N2 - Between March 1984 and July 1990 our team transplanted 168 hearts. One hundred twelve patients did not require mechanical support (group I). Fifty- six patients required mechanical support (group II). Intraaortic balloon counterpulsation was used in 37 patients (66%). The total artificial heart (TAH) was used in 16 patients (29%), and the ventricular assist device (VAD) was used in three patients (5%). The time spent on the device ranged from 1 to 35 days. No statistical difference was noted on the survival between the two groups. The 30-day and 1-year survival rate was 95% (106 patients) and 71% (79 patients) in group I and 91% (51 patients) and 68% (38 patients) in group II. As of July 31, 1990, 70% in group I and 68% in group II are alive. No significant differences were found between the two groups for the following variables (after heart transplantation): length of stay, 30-day survival, 1-year survival, and complications. The only significant difference found between the two groups was the incidence of infections: group I, 23%; group II, 51.7% (p = 0.001). Mechanical support as a bridge to transplantation provides excellent support until a donor becomes available. No difference was found in the 30-day and 1-year survival between the two groups.
AB - Between March 1984 and July 1990 our team transplanted 168 hearts. One hundred twelve patients did not require mechanical support (group I). Fifty- six patients required mechanical support (group II). Intraaortic balloon counterpulsation was used in 37 patients (66%). The total artificial heart (TAH) was used in 16 patients (29%), and the ventricular assist device (VAD) was used in three patients (5%). The time spent on the device ranged from 1 to 35 days. No statistical difference was noted on the survival between the two groups. The 30-day and 1-year survival rate was 95% (106 patients) and 71% (79 patients) in group I and 91% (51 patients) and 68% (38 patients) in group II. As of July 31, 1990, 70% in group I and 68% in group II are alive. No significant differences were found between the two groups for the following variables (after heart transplantation): length of stay, 30-day survival, 1-year survival, and complications. The only significant difference found between the two groups was the incidence of infections: group I, 23%; group II, 51.7% (p = 0.001). Mechanical support as a bridge to transplantation provides excellent support until a donor becomes available. No difference was found in the 30-day and 1-year survival between the two groups.
UR - http://www.scopus.com/inward/record.url?scp=0026551387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026551387&partnerID=8YFLogxK
M3 - Article
C2 - 1576127
AN - SCOPUS:0026551387
SN - 1053-2498
VL - 11
SP - 235
EP - 239
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 2 I
ER -